Michael E. DeBakey Veterans Affairs Medical Center in Houston

PARAPRO'S THOUGHT LEADER AI: WHERE ARTIFICIAL INTELLIGENCE MEETS SCABIES EXPERTISE

Retrieved on: 
Thursday, October 26, 2023
FAAD, Institute for Creative Technologies, Michael, FDA, The Pediatric Infectious Disease Journal, Health care, Scabies, Infection, Michael E. DeBakey Veterans Affairs Medical Center in Houston, Pediatrics, Baylor College of Medicine, University, ICT, Hospital, Diagnosis, Baylor University, Creative Technology, Head, Medical device, Veterinary medicine, Dermatology, MD, FAAP

CARMEL, Ind., Oct. 26, 2023 /PRNewswire/ -- ParaPRO, a leading specialty pharmaceutical company specializing in innovative treatments for human ectoparasites, has unveiled Thought Leader AI. This cutting-edge decision support tool, developed in collaboration with the Institute for Creative Technologies (ICT) at the University of Southern California, enables healthcare practitioners to conduct lifelike consultations with top scabies specialists. From diagnosis to treatment, Thought Leader AI aims to support clinical decision-making and foster a virtual exchange of expert insights. Healthcare providers can visit www.thoughtleaderai.org to experience Thought Leader AI in action. Non-healthcare providers can contact [email protected] to receive instructions on how to access the platform.

Key Points: 
  • From diagnosis to treatment, Thought Leader AI aims to support clinical decision-making and foster a virtual exchange of expert insights.
  • Healthcare providers can visit www.thoughtleaderai.org to experience Thought Leader AI in action.
  • Thought Leader AI also informs clinicians about available treatment options, including the first and only FDA-approved 'complete cure' for scabies."
  • Thought Leader AI addresses these challenges head-on, allowing practitioners to seek real-time expert advice, gain invaluable clinical insights, and explore best practices.

Max Hirshkowitz, PhD, Receives National Sleep Foundation's Lifetime Achievement Award

Retrieved on: 
Monday, May 1, 2023
Consensus, BPS Barbara Wilson Lifetime Achievement Award, Polysomnography, Consumer Technology Association, NSF, Sleep, Baylor University, National Sleep Foundation, CTA, Michael E. DeBakey Veterans Affairs Medical Center in Houston, Research, Doctor of Philosophy, Sleep Research Society, Insomnia, Stanford University School of Medicine, Public health, Sleep medicine, Chairperson, Obstructive sleep apnea, NIH, Chair, Pharmaceutical industry, Nursing

WASHINGTON, May 1, 2023 /PRNewswire/ -- National Sleep Foundation (NSF) announced today that Max Hirshkowitz, PhD, has received its Lifetime Achievement Award.

Key Points: 
  • WASHINGTON, May 1, 2023 /PRNewswire/ -- National Sleep Foundation (NSF) announced today that Max Hirshkowitz, PhD, has received its Lifetime Achievement Award.
  • The Lifetime Achievement Award is the organization's highest honor, recognizing an individual who has demonstrated exemplary leadership in the field of sleep health.
  • He has authored hundreds of peer-reviewed articles and served on the editorial board of multiple journals including Sleep Health, Sleep Medicine, and Sleep Research.
  • To learn more about the National Sleep Foundation's Lifetime Achievement Award, visit the NSF website .

PARAPRO PRESENTS THE FUTURE OF SCIENTIFIC EXCHANGE AT MAUI DERM HAWAII 2023

Retrieved on: 
Monday, February 6, 2023
FAAD, Diagnosis, Michael E. DeBakey Veterans Affairs Medical Center in Houston, Baylor University, Scabies, Knowledge, FDA, Baylor College of Medicine, Public, Michael, Oral, MD, Medical device, Dermatology

CARMEL, Ind., Feb. 6, 2023 /PRNewswire/ -- ParaPRO, a specialty pharmaceutical company focused on innovative treatments for human ectoparasites, introduced Thought Leader AI – a pioneering medical education platform that enables healthcare practitioners to engage "live" with leading clinical experts on topics of public health at Maui Derm Hawaii 2023. The presentation was moderated by Maui Derm founder, Dr. George Martin, during a "Talk Story" session on January 23, 2023. Attendees were among the first to experience the educational benefits of Thought Leader AI specific to the identification, diagnosis, and treatment of scabies, a common, but underrepresented health concern.

Key Points: 
  • CARMEL, Ind., Feb. 6, 2023 /PRNewswire/ -- ParaPRO , a specialty pharmaceutical company focused on innovative treatments for human ectoparasites, introduced Thought Leader AI – a pioneering medical education platform that enables healthcare practitioners to engage "live" with leading clinical experts on topics of public health at Maui Derm Hawaii 2023.
  • The presentation was moderated by Maui Derm founder, Dr. George Martin , during a "Talk Story" session on January 23, 2023.
  • "We were excited to share Thought Leader AI with conference attendees," said Bill Culpepper III, President of ParaPRO.
  • Thought Leader AI also informs clinicians about available treatment options, including the first and only FDA-approved "complete cure" for scabies."

PARAPRO INTRODUCES THE FIRST AI-BASED INTERACTIVE MEDICAL EDUCATION PLATFORM AT THE AMERICAN ACADEMY OF PEDIATRICS NATIONAL CONFERENCE AND EXHIBITION

Retrieved on: 
Friday, October 7, 2022
AAP, Approved Drug Products with Therapeutic Equivalence Evaluations, Physician, FAAD, CA, Orange Book, Time, Scabies, Parasitism, Hospital, Hominis, Conference, Diagnosis, Drug, Michael E. DeBakey Veterans Affairs Medical Center in Houston, Feinberg School of Medicine, Regulation of food and dietary supplements by the U.S. Food and Drug Administration, U.S. FDA, Patient, Infection, ICT, Baylor University, Multimedia, Technology, Centers for Disease Control and Prevention, Exhibition, Knowledge, University, Food, Center, Michael, Learning, Creative Technology, National Conference, Egg, American Academy, Skin, Artificial intelligence, Pediatrics (journal), The Pediatric Infectious Disease Journal, FDA, Baylor College of Medicine, View, Public health, Medical device, Medicine, Veterinary medicine, Pharmaceutical industry, FAAP, Dermatology, Medicine, Pediatrics, MD

CARMEL, Ind. , Oct. 7, 2022 /PRNewswire/ -- ParaPRO, a specialty pharmaceutical company focused on innovative treatments for human ectoparasites, today announced that it will unveil Thought Leader AI – a pioneering medical education platform that enables healthcare practitioners to engage "live" with leading clinical experts on topics of public health – at the American Academy of Pediatrics (AAP) National Conference & Exhibition in Anaheim, CA, October 7-11, 2022. The introduction of Thought Leader AI marks the first time Artificial Intelligence (AI)-based, user-directed interactive technology will be used for advancing scientific exchange.

Key Points: 
  • Because many physicians don't often see scabies in their practices, it is frequently misdiagnosed or mistreated.
  • This new technologyallows us to share the knowledge and clinical experiences held by a select few with practitioners everywhere, regardless of the physical barriers to in-person interaction."
  • "Enabling prescribers to become agents in their own learning will redefine inquiry-based medical education for years to come."
  • Thought Leader AI is a pioneering medical education platform to advance public health.